Biomedical Engineering Reference
In-Depth Information
Desai, K., Xiao, N., Wang, W., Gangi, L., Greene, J., et al. 2002. Initiating oncogenic event
determines gene-expression patterns of human breast cancer models. Proceedings of the
National Academy of Science USA 99: 6967-6972.
Eriksson, M., Guse, K., Bauerschmitz, G., Virkkunen, P., Tarkkanen, M., et al. 2007.
Oncolytic adenoviruses kill breast cancer initiating CD44(+)CD24(-/low) cells. Molecular
Therapy 12: 2060-2061.
Fidler, I. and Talmadge, J. 1986. Evidence that intravenously derived murine pulmonary
melanoma metastases can originate from the expansion of a single tumor cell. Cancer
Research 46: 5167-5171.
Furger, K., Menon, R., Tuck, A., Bramwell, V., and Chambers, A. 2001. The functional and
clinical roles of osteopontin in cancer and metastasis. Current Molecular Medicine 1: 621-632.
Gotzmann, J., Fischer, A.N.M., Zojer, M., Mikula, M., Proell, V., Huber, H., Jechlinger, M.,
Waerner, T., Weith, A., Beug, H., and Mikulits, W. 2006. A crucial function of PDGF in
TGF-B-mediated cancer progression of hepatocytes. Oncogene 25: 3170-3185.
Guise, T., Mohammad, K., Clines, G., Stebbins, E., Wong, D., et al. 2006. Basic mechanisms
responsible for osteolytic and osteoblastic bone metastases. Clinical Cancer Research 12:
6213s-6216s.
Gupta, G. and Massague, J. 2006. Cancer metastasis: building a framework. Cell 127:
679-695.
Hanahan, D. and Weinberg, R. 2000. The hallmarks of cancer. Cell 100: 57-70.
Hermann, P., Huber, S., Herrier, T., Aicher, A., Ellwart, J., et al. 2007. Distinct populations
of cancer stem cells determine tumor growth and metastatic activity in human pancreatic
cancer. Cell Stem Cell 1: 313-323.
Hermann, P., Huber, S., and Heeschen, C. 2008. Metastatic cancer stem cells: a new target for
anti-cancer therapy? Cell Cycle 7: 188-193.
Hiratsuka, S., Watanabe, A., Aburatani, J., and Maru, Y. 2006. Tumour-mediated upregula-
tion of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.
Nature Cell Biology 8: 1369-1375.
Ho, M., Ng, A., Lam, S., and Hung, J. 2007. Side population in human lung cancer cell lines
and tumors is enriched with stem-like cancer cells. Cancer Research 67: 4827-4833.
Hu, G., Chong, R.A., Yang, Q., Wei, Y., Blanco, M.A., Li, F., Reiss, M., Au, J.L., Haffy, B.,
and Kang, Y. 2009. MTDH activation by 8q22 genomic gain promotes chemoresistance
and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
Hurwitz, J., Fehrenbacher, L., Novonty, W., Cartwright, T., Hainsworth, J., Heim, W.,
Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers, B., Ross,
R., and Kabbinavar, F. 2004. Bevacizumab plus irinotecan, fluorouracil, and leucovorin
for metastatic colorectal cancer. New England Journal of Medicine 350: 2335-2342.
Hynes, R. 2003. Metastatic potential: generic predisposition of the primary tumor or rare,
metastatic variants—or both? Cell 113: 821-823.
Ince, T., Richardson, A., Bell, G., Saitoh, M., Godar, S., et al. 2007. Transformation of
different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell
12: 160-170.
Ito, M., Yang, Z., Andl, T., Cui, C., Kim, N., et al. 2007. Wnt-dependant de novo hair follicle
regeneration in adult mouse skin after wounding. Nature 447: 316-320.
Jain, R. 2001. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm
for combination therapy. Nature Medicine 7: 987-989.
Jamieson, C., Ailles, L., Dylla, S., Muijtjens, M., Jones, C., et al. 2004. Granulocyte-macro-
phage progenitors as candidate leukemic stem cells in blast-crisis CML. New England
Journal of Medicine 351: 657-667.
Jemal, A., Siegel, R., Ward, W., Murray, T., Xu, J., et al. 2007. Cancer statistics, 2007. CA
Cancer Journal of Clinicians 57: 43-66.
Jin, L., Hope, K., Zhai, Q., Smadja-Joffe, F., and Dick, J. 2006. Targeting of CD44 eradicates
human acute myeloid leukemic stem cells. Nature Medicine 12: 1167-1174.
